Merck & Co Inc (MRK) Common Stock USD0.50

Sell:$89.22Buy:$89.23$1.63 (0.00%)

Dow Jones:1.69%
Market closed | Prices delayed by at least 15 minutes
Sell:$89.22
Buy:$89.23
Change:$1.63 (0.00%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$89.22
Buy:$89.23
Change:$1.63 (0.00%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Merck & Co., Inc. is a research-intensive biopharmaceutical company engaged in research to deliver health solutions that advance the prevention and treatment of diseases in people and animals. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. It is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.

Key people

Robert M. Davis
Chairman of the Board, President, Chief Executive Officer
Caroline Litchfield
Chief Financial Officer, Executive Vice President
Betty D. Larson
Chief Human Resource Officer
David M. Williams
Executive Vice President, Chief Information and Digital Officer
Jennifer L. Zachary
Executive Vice President, General Counsel, Corporate Secretary
Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Richard R. Deluca
Executive Vice President, President - Merck Animal Health
Cristal N. Downing
Executive Vice President, Chief Communications and Public Affairs Officer
Michael A. Klobuchar
Executive Vice President, Chief Strategy Officer
Dean Y. Li
Executive Vice President, President - Merck Research Laboratories
Thomas Henry Glocer
Lead Independent Director
Surendralal L. Karsanbhai
Director
Douglas M. Baker
Independent Director
Mary Ellen Coe
Independent Director
Pamela J. Craig
Independent Director
Click to see more

Key facts

  • EPIC
    MRK
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US58933Y1055
  • Market cap
    $222.57bn
  • Employees
    75,000
  • Shares in issue
    3.58bn
  • Exchange
    New York Stock Exchange
  • Index
    Dow Industry, S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.